Description:

North Central Cancer Treatment Group N0577 End Of Active Treatment/Cancel Notification Form (Submit Once Per Patient) NCT00887146 Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C090D31-BAA2-2FAA-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C090D31-BAA2-2FAA-E044-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 8/26/12
  2. 1/8/15
  3. 1/8/15
  4. 6/8/15
Uploaded on:

June 8, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

North Central Cancer Treatment Group N0577 End Of Active Treatment/Cancel Notification Form NCT00887146

No Instruction available.

  1. StudyEvent: North Central Cancer Treatment Group N0577 End Of Active Treatment/Cancel Notification Form
    1. No Instruction available.
Header
Are data amended (If yes, highlight amended areas)
Preregistration Screening Failure
This patient will now go to (check one See Schema and Section 13.0 of the protocol)
Reason Treatment Ended (check one)